申请人:Astellas Pharma Inc.
公开号:EP2511265A1
公开(公告)日:2012-10-17
[Problem]
A compound which is useful as a GK activator is provided.
[Means for Solution]
The present inventors have conducted studies on compounds having a GK activating action, which are promising as active ingredients of pharmaceutical compositions for the treatment of diabetes, type 2 diabetes mellitus, obesity, metabolic syndrome and related diseases caused by the aforementioned diseases, and as a result, they have confirmed that a benzamide compound of the present invention has an excellent GK activating action, thereby completing the present invention. That is, the benzamide compound of the present invention has a GK activating action and can be used as an agent for preventing and/or treating diabetes, type 2 diabetes mellitus, obesity, metabolic syndrome, and related diseases caused by the aforementioned diseases.
提供一种作为GK激活剂有用的化合物。本发明人对具有GK激活作用的化合物进行了研究,这些化合物被认为是治疗糖尿病、2型糖尿病、肥胖、代谢综合征以及由上述疾病引起的相关疾病的药物组合的有效成分,并且结果表明,本发明的苯甲酰胺化合物具有出色的GK激活作用,从而完成了本发明。换句话说,本发明的苯甲酰胺化合物具有GK激活作用,可用作预防和/或治疗糖尿病、2型糖尿病、肥胖、代谢综合征以及由上述疾病引起的相关疾病的药剂。